Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanas Koynov

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Drug Development and Industrial Pharmacy|January 5, 2019
Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material propertiesLuke Schenck, Athanas Koynov, Aaron Cote
Biotechnology and Bioengineering|December 13, 2006
Characterization of the localized hydrodynamic shear forces and dissolved oxygen distribution in sparged bioreactorsAthanas Koynov, Grétar Tryggvason, Johannes G Khinast
Pharmaceutics|December 28, 2021
Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of PosaconazoleDerek Frank, Luke Schenck, Athanas Koynov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 26, 2023
Drug delivery breakthrough technologies - A perspective on clinical and societal impactBeate Bittner, Manuel Sánchez-Félix, Dennis Lee, et al.
Journal of Pharmaceutical Sciences|December 8, 2023
A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical IndustryLuke Schenck, Bailey Risteen, Lindsay Michelle Johnson, et al.
Nature Communications|November 7, 2024
In silico formulation optimization and particle engineering of pharmaceutical products using a generative artificial intelligence structure synthesis methodTimothy Hornick, Chen Mao, Athanas Koynov, et al.
Journal of Pharmaceutical Sciences|July 17, 2017
Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical PropertiesAmanda K P Mann, Luke Schenck, Athanas Koynov, et al.
Molecular Pharmaceutics|February 7, 2024
Poly(vinylpyridine-<i>co</i>-vinylpyridine <i>N</i>-oxide) Excipients Mediate Rapid Dissolution and Sustained Supersaturation of Posaconazole Amorphous Solid DispersionsYu-Sheng Liu, Joseph Della Rocca, Luke Schenck, et al.
Pharmaceutical Research|December 1, 2021
Correlative Image-Based Release Prediction and 3D Microstructure Characterization for a Long Acting Parenteral ImplantZhen Liu, Li Li, Shawn Zhang, et al.
Molecular Pharmaceutics|April 26, 2019
Molecular Interactions in Posaconazole Amorphous Solid Dispersions from Two-Dimensional Solid-State NMR SpectroscopyXingyu Lu, Chengbin Huang, Michael B Lowinger, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Drug Development and Industrial Pharmacy|January 5, 2019
Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material propertiesLuke Schenck, Athanas Koynov, Aaron Cote
Biotechnology and Bioengineering|December 13, 2006
Characterization of the localized hydrodynamic shear forces and dissolved oxygen distribution in sparged bioreactorsAthanas Koynov, Grétar Tryggvason, Johannes G Khinast
Pharmaceutics|December 28, 2021
Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of PosaconazoleDerek Frank, Luke Schenck, Athanas Koynov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 26, 2023
Drug delivery breakthrough technologies - A perspective on clinical and societal impactBeate Bittner, Manuel Sánchez-Félix, Dennis Lee, et al.
Journal of Pharmaceutical Sciences|December 8, 2023
A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical IndustryLuke Schenck, Bailey Risteen, Lindsay Michelle Johnson, et al.
Nature Communications|November 7, 2024
In silico formulation optimization and particle engineering of pharmaceutical products using a generative artificial intelligence structure synthesis methodTimothy Hornick, Chen Mao, Athanas Koynov, et al.
Journal of Pharmaceutical Sciences|July 17, 2017
Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical PropertiesAmanda K P Mann, Luke Schenck, Athanas Koynov, et al.
Molecular Pharmaceutics|February 7, 2024
Poly(vinylpyridine-<i>co</i>-vinylpyridine <i>N</i>-oxide) Excipients Mediate Rapid Dissolution and Sustained Supersaturation of Posaconazole Amorphous Solid DispersionsYu-Sheng Liu, Joseph Della Rocca, Luke Schenck, et al.
Pharmaceutical Research|December 1, 2021
Correlative Image-Based Release Prediction and 3D Microstructure Characterization for a Long Acting Parenteral ImplantZhen Liu, Li Li, Shawn Zhang, et al.
Molecular Pharmaceutics|April 26, 2019
Molecular Interactions in Posaconazole Amorphous Solid Dispersions from Two-Dimensional Solid-State NMR SpectroscopyXingyu Lu, Chengbin Huang, Michael B Lowinger, et al.
Pageof 2